Delivery Order SPE2DB22D3016-SPE2DB25FBDM0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,045.60 to AmerisourceBergen Drug Corp for 60 tablets of Topamax 25 mg. This non-competitive, firm fixed-price delivery order was awarded on July 18, 2025, with an ultimate completion date of July 21, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order represents a discrete transaction under the company's larger...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Topamax 100 mg tablets. The contract is valued at $8,896.67 and has an ultimate completion date of April 2, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, valued at up to $999,999,999.00 and with a performance period through...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the supply of Topamax 50 mg tablets, a pharmaceutical product, with a ceiling value of $1,029.00. The contract is a firm-fixed-price delivery order with a period of performance through September 30, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Topamax 25 mg sprinkle capsules (60 count) with a ceiling value of $2,914.86. This firm fixed-price contract utilizes no set-aside provisions and reflects competitive procurement practices. The delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a $12,893.60 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TOPAMAX 50 MG TABLET 60S, a pharmaceutical product. This delivery order contract has an ultimate completion date of March 18, 2024 and was awarded on March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Topamax 100 mg tablets in a quantity of 60 units, with a ceiling value of $19,206.93. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 8, 2025. The vendor will perform work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of Topamax 50 mg tablets, a brand name anticonvulsant medication. The delivery order has a ceiling value of $5,556.59 and a performance period through March 15, 2024. This delivery order is issued under a larger indefinite delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Topamax (topiramate) 25 mg sprinkle capsules in a quantity of 60 units. This competitively awarded contract, valued at $2,756.25, utilizes firm fixed-price terms with a completion date of July 23, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Topiramate 50 mg tablets in quantities of 1,000 units, with a contract ceiling value of $2,278.74 and an ultimate completion date of August 20, 2025. This is a firm fixed price, non-set-aside delivery order executed under a competitive procurement process. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Topamax 100 mg tablets, a medication used to treat neurological conditions. The contract has a firm fixed price, a ceiling value of $3,045.01, and a performance period ending on April 30, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBDM0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Topamax (topiramate) 50 mg tablets in quantities of 60 units, with a ceiling value of $3,052.09. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The contract is scheduled for ultimate completion by July 31, 2025, and represents a short-duration fulfillment of pharmaceutical requirements for federal medical supply needs. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and has demonstrated capability to meet DLA requirements across multiple therapeutic domains through competitively awarded contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 7/30/25 |